AbbVie Inc. (ABBV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 6B 12B 18B Q3 '21: 14.3B Q4 '21: 14.9B Q1 '22: 13.5B Q2 '22: 14.6B Q3 '22: 14.8B Q4 '22: 15.1B Q1 '23: 12.2B Q2 '23: 13.9B Q3 '23: 13.9B Q4 '23: 14.3B Q1 '24: 12.3B Q2 '24: 14.5B Q3 '24: 14.5B Q4 '24: 15.1B Q1 '25: 13.3B Q2 '25: 15.4B Q3 '25: 15.8B Q4 '25: 16.6B Q1 '26: 15B Q2 '26: 17B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 5B 10B 15B Q3 '16: 4.9B Q4 '16: 5.2B Q1 '17: 4.9B Q2 '17: 5.4B Q3 '17: 5.4B Q4 '17: 5.5B Q1 '18: 6B Q2 '18: 6.3B Q3 '18: 6.4B Q4 '18: 6.3B Q1 '19: 6.1B Q2 '19: 6.4B Q3 '19: 6.6B Q4 '19: 6.7B Q4 '20: 9.2B Q4 '21: 10.6B Q4 '22: 11B Q4 '23: 8.6B Q4 '24: 10.7B Q4 '25: 12.1B Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19 Q4 '22 Q4 '25

Operating Income Quarterly

0 2.5B 5B 7.5B Q2 '21: 4.4B Q3 '21: 4.3B Q4 '21: 5.1B Q1 '22: 4.7B Q2 '22: 3.3B Q3 '22: 4.6B Q4 '22: 5.5B Q1 '23: 2.8B Q2 '23: 4.5B Q3 '23: 2.3B Q4 '23: 3.2B Q1 '24: 2.8B Q2 '24: 4B Q3 '24: 3.8B Q1 '25: 3.7B Q2 '25: 4.9B Q3 '25: 1.9B Q4 '25: 4.5B Q1 '26: 4B Q2 '26: 6.4B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Net Income Quarterly

-2B 0 2B 4B 6B Q3 '21: 3.2B Q4 '21: 4B Q1 '22: 4.5B Q2 '22: 924M Q3 '22: 3.9B Q4 '22: 2.5B Q1 '23: 239M Q2 '23: 2B Q3 '23: 1.8B Q4 '23: 822M Q1 '24: 1.4B Q2 '24: 1.4B Q3 '24: 1.6B Q4 '24: -22M Q1 '25: 1.3B Q2 '25: 938M Q3 '25: 186M Q4 '25: 1.8B Q1 '26: 695M Q2 '26: 3.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 2.5B 5B 7.5B Q3 '21: 4.4B Q4 '21: 4.3B Q1 '22: 4.1B Q2 '22: 4.2B Q3 '22: 5B Q4 '22: 4.2B Q1 '23: 4B Q2 '23: 4.2B Q3 '23: 6.5B Q4 '23: 5.7B Q1 '24: 4.1B Q2 '24: 4.2B Q3 '24: 4.2B Q4 '24: 4.4B Q1 '25: 4B Q2 '25: 4.3B Q3 '25: 5.3B Q4 '25: 4.6B Q1 '26: 4.2B Q2 '26: 4.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

0 3B 6B 9B Q3 '21: 7.9B Q4 '21: 5.1B Q1 '22: 4.9B Q2 '22: 5B Q3 '22: 7.6B Q4 '22: 7.4B Q1 '23: 4.2B Q2 '23: 6.3B Q3 '23: 7.6B Q4 '23: 4.8B Q1 '24: 4B Q2 '24: 2.3B Q3 '24: 5.4B Q4 '24: 7B Q1 '25: 1.6B Q2 '25: 5.2B Q3 '25: 7B Q4 '25: 5.2B Q1 '26: 3.8B Q2 '26: 3.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

0 3B 6B 9B Q3 '21: 7.7B Q4 '21: 4.9B Q1 '22: 4.7B Q2 '22: 4.9B Q3 '22: 7.4B Q4 '22: 7.2B Q1 '23: 4B Q2 '23: 6.1B Q3 '23: 7.4B Q4 '23: 4.5B Q1 '24: 3.8B Q2 '24: 2B Q3 '24: 5.2B Q4 '24: 6.8B Q1 '25: 1.4B Q2 '25: 4.9B Q3 '25: 6.6B Q4 '25: 4.9B Q1 '26: 3.6B Q2 '26: 3.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q1 '20: 1.5B Q2 '20: 1.6B Q3 '20: 1.8B Q1 '21: 1.8B Q2 '21: 1.8B Q3 '21: 1.8B Q1 '22: 1.8B Q2 '22: 1.8B Q3 '22: 1.8B Q1 '23: 1.8B Q2 '23: 1.8B Q3 '23: 1.8B Q1 '24: 1.8B Q2 '24: 1.8B Q3 '24: 1.8B Q1 '25: 1.8B Q2 '25: 1.8B Q3 '25: 1.8B Q1 '26: 1.8B Q2 '26: 1.8B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.00 6.00 9.00 Q3 '21: 4.20 Q4 '21: 6.45 Q1 '22: 6.97 Q2 '22: 7.06 Q3 '22: 7.49 Q4 '22: 6.61 Q1 '23: 4.23 Q2 '23: 4.86 Q3 '23: 3.65 Q4 '23: 2.73 Q1 '24: 3.37 Q2 '24: 3.00 Q3 '24: 2.88 Q4 '24: 2.40 Q1 '25: 2.35 Q2 '25: 2.10 Q3 '25: 1.32 Q4 '25: 2.36 Q1 '26: 2.03 Q2 '26: 3.54 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.